Orbimed Advisors - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$2,825,000
+32.2%
22,800
-29.2%
0.04%
-2.4%
Q3 2019$2,137,000
-81.4%
32,200
-71.7%
0.04%
-80.7%
Q4 2018$11,470,000
-48.9%
113,800
-70.5%
0.21%
-0.9%
Q3 2017$22,425,000
-78.4%
386,380
-54.9%
0.21%
-80.3%
Q2 2017$103,703,000
-11.6%
856,554
-17.4%
1.09%
-18.2%
Q1 2017$117,285,000
-3.6%
1,037,000
-7.4%
1.33%
-14.3%
Q4 2016$121,688,000
-34.0%
1,120,0000.0%1.55%
-26.1%
Q3 2016$184,341,000
+15.4%
1,120,0000.0%2.10%
+25.8%
Q2 2016$159,802,000
+11.1%
1,120,0000.0%1.67%
+10.2%
Q1 2016$143,886,000
-14.0%
1,120,0000.0%1.51%
-0.1%
Q4 2015$167,272,000
-10.0%
1,120,0000.0%1.52%
-19.2%
Q3 2015$185,763,000
-31.3%
1,120,0000.0%1.88%
-5.5%
Q2 2015$270,346,000
-14.4%
1,120,0000.0%1.98%
-26.4%
Q1 2015$315,862,000
+36.3%
1,120,000
-24.6%
2.70%
+21.8%
Q4 2014$231,660,000
-34.1%
1,485,0000.0%2.21%
-39.7%
Q3 2014$351,485,000
-10.2%
1,485,000
-10.3%
3.67%
-20.1%
Q2 2014$391,298,000
-31.6%
1,656,258
-4.5%
4.60%
-34.7%
Q1 2014$572,164,000
+383.0%
1,734,9340.0%7.04%
+304.1%
Q4 2013$118,461,000
-20.2%
1,734,934
-19.4%
1.74%
-34.3%
Q3 2013$148,525,000
+54.0%
2,151,607
+0.0%
2.65%
+29.6%
Q2 2013$96,434,0002,150,6342.04%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders